http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I416105-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ada68032e6c5599de33d868231aaa52d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3cbdb1ae77ae740561150b6860663cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa76ba5302a9836915affb5ecc4fc797 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74bb9080b2d06348e458adb89c7dfa86 |
| publicationDate | 2013-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I416105-B |
| titleOfInvention | Biomarker for distinguishing community-type methicillin-resistant Staphylococcus aureus from hospital-type methicillin-resistant Staphylococcus aureus |
| abstract | Rapid identification of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is essential for appropriate clinical therapy and timely intervention for cross-infection control. By screening methicillin-sensitive Staphylococcus aureus (MSSA), CA-MRSA, hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA), heterogeneous Vancomycin-intermediate Staphylococcus aureus (h-VISA) and Vancomycin-intermediate Staphylococcus aureus (VISA) strains with MALDI-TOF, the peptide peak, GIIKX1IKX2LIEX3FTGK (wherein X1 is F or V; when X1 is F, X2 is G and X3 is K; and when X1 is V, X2 is S and X3 is Q), was found to be able to discriminate between HA-MRSA and CA-MRSA strains, and thus it can be a biomarker to identify CA-MRSA in MRSA strains. |
| priorityDate | 2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.